
Florida Cancer Specialists & Research Institute Appoints Richard McDonough, MD Director of Patient Advocacy
Florida Cancer Specialists & Research Institute, LLC has appointed medical oncologist and hematologist Richard McDonough, MD, as Director of Patient Advocacy for the statewide practice.
Fort Myers, Fla., October 11, 2023 – Florida Cancer Specialists & Research Institute, LLC (FCS) has appointed medical oncologist and hematologist
Throughout his career, Dr. McDonough has played a leadership role in advocating on behalf of cancer patients. He is a long-standing active member of the Florida Society of Clinical Oncology (FLASCO). He served as FLASCO President from 2017 to 2019 and as the FLASCO representative to the American Society of Clinical Oncology (ASCO) State Affiliate Committee for several years. He has also served on the FLASCO Board of Directors and currently serves FLASCO Director of Fellow Initiatives and as Chair of the Nominating Committee. Dr. McDonough is also a member of the Government Affairs Committee for the Community Oncology Alliance.
“As a recognized national leader, we at FCS are proud of our commitment and track record of affecting positive change in cancer care delivery and clinical research,” said FCS Chief Executive Officer
Board-certified in oncology, Hematology and internal medicine, Dr. McDonough earned his medical degree from the University of Miami, where he also completed his residency training in internal medicine at Jackson Memorial Hospital. He completed a fellowship in hematology/oncology at the Mayo Clinic in Jacksonville, Florida. He has extensive experience in clinical research with a focus on cervical spine conditions, treatments and surgical reconstruction.







































